Why Purity Matters: advancing lentiviral vector purification at VIVEbiotech

At VIVEbiotech, we are committed to delivering the highest quality lentiviral vectors (LVVs) for gene therapy applications. As in vivo projects demand increasingly higher doses, controlling impurity levels has become more critical than ever.

Two impurities—residual DNA and host cell proteins—require special attention to guarantee patient safety. To address this challenge, we are advancing purification strategies based on orthogonal design principles, combining multiple approaches to achieve the highest purity standards.

This is not just about improving product quality; it is a fundamental requirement to ensure safe and effective treatments for patients.

Watch the full video featuring Patricio, President and Board Member at VIVEbiotech, to learn more about how we are driving innovation in LVV purification.